Ö. Başaran Et Al. , "Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.," Journal of thrombosis and thrombolysis , vol.43, no.2, pp.157-165, 2017
Başaran, Ö. Et Al. 2017. Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.. Journal of thrombosis and thrombolysis , vol.43, no.2 , 157-165.
Başaran, Ö., Dogan, V., Beton, O., Tekinalp, M., Aykan, A. Ç., Kalaycıoğlu, E., ... Bolat, I.(2017). Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.. Journal of thrombosis and thrombolysis , vol.43, no.2, 157-165.
Başaran, Özcan Et Al. "Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.," Journal of thrombosis and thrombolysis , vol.43, no.2, 157-165, 2017
Başaran, Özcan Et Al. "Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.." Journal of thrombosis and thrombolysis , vol.43, no.2, pp.157-165, 2017
Başaran, Ö. Et Al. (2017) . "Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.." Journal of thrombosis and thrombolysis , vol.43, no.2, pp.157-165.
@article{article, author={Özcan Başaran Et Al. }, title={Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study.}, journal={Journal of thrombosis and thrombolysis}, year=2017, pages={157-165} }